This 2012 review by Gary A. Brent in the Journal of Clinical Investigation provides an in-depth exploration of how thyroid hormones (TH), primarily triiodothyronine (T3) and thyroxine (T4), exert their effects through genomic and non-genomic mechanisms. Genomic actions occur via T3 binding to nuclear thyroid hormone receptors (TRα and TRβ),
This article explores the physiological mechanisms of alpha-lipoic acid (ALA) and its potential therapeutic applications for metabolic syndrome. The study highlights how ALA acts as an antioxidant, improving insulin sensitivity, reducing inflammation, and protecting against oxidative stress. It discusses the evidence supporting ALA’s effectiveness in managing components of metabolic syndrome,
This pooled analysis of two prospective observational registry studies evaluated the long-term effects of testosterone undecanoate therapy in 156 obese hypogonadal men with type 2 diabetes mellitus (T2DM) over a period of up to 6 years. Testosterone treatment led to significant and sustained reductions in weight (mean loss of 17.49
This 2012 review examines the potential role of testosterone therapy in managing obesity among hypogonadal men. Obesity impairs testicular testosterone production, leading to a cycle of increased fat accumulation, particularly visceral fat, which is associated with metabolic syndrome and type 2 diabetes. Testosterone therapy has been shown to reverse fat
This 2015 observational study published in Nutrition Research analyzed data from 9,148 U.S. adults aged 40 and older using NHANES 2005–2010 to examine the relationship between dietary magnesium intake, C-reactive protein (CRP), and the prevalence of metabolic syndrome (MetS). The study found that individuals in the highest quintile of magnesium
This study examined the effects of dietary methionine restriction (MR) on fat oxidation and metabolic health in obese adults with metabolic syndrome. Over 16 weeks, participants who followed a low-methionine diet showed a 12.1% increase in fat oxidation and a significant reduction in liver fat content compared to the control
This 1998 animal study published in the Journal of the American College of Nutrition explored the effects of magnesium deficiency on cardiovascular, metabolic, and lipid parameters in rats. Over a 21-day period, rats on a magnesium-deficient diet developed cardiac arrhythmias, impaired glucose tolerance, and significantly reduced serum cholesterol levels. The
This 2009 meta-analysis published in Magnesium Research assessed the relationship between dietary magnesium intake and risk of metabolic syndrome (MetS) by analyzing data from nine observational studies involving over 30,000 participants. The findings showed that individuals with the highest magnesium intake had a 31% lower risk of developing MetS compared
This meta-analysis reviewed the effects of garlic supplementation on components of metabolic syndrome, including cholesterol levels, blood glucose, blood pressure, and inflammation. The results showed that garlic significantly reduced total cholesterol, LDL cholesterol, and triglycerides while increasing HDL cholesterol. It also led to decreases in fasting blood glucose and systolic
This review explores the potential of L-carnosine and its carnosinase-resistant derivatives in preventing and treating vascular complications in diabetes. L-carnosine acts as a scavenger of reactive carbonyl species (RCS), helping to reduce the formation of harmful advanced glycation end-products (AGEs) and advanced lipoxidation end-products (ALEs), both of which contribute to
